Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) — Free Cash Flow Generation Index
Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) has a Free Cash Flow Generation Index of 0.61x as of September 2024. Free cash flow of CN¥31.63 Million represents 1% of operating cash flow (CN¥51.50 Million). Explore Jiangsu Lianhuan Pharmaceutical Co Ltd (600513) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Jiangsu Lianhuan Pharmaceutical Co Ltd Free Cash Flow Generation Index (2002–2024)
Historical FCF Generation Index trend for Jiangsu Lianhuan Pharmaceutical Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see Jiangsu Lianhuan Pharmaceutical Co Ltd cash conversion from operations.
Annual Free Cash Flow Generation for Jiangsu Lianhuan Pharmaceutical Co Ltd (2002–2024)
Year-by-year Free Cash Flow Generation Index for Jiangsu Lianhuan Pharmaceutical Co Ltd. Check Jiangsu Lianhuan Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -16.17x | CN¥-174.08 Million | CN¥10.77 Million | CN¥184.84 Million | ▼ -6402.0% |
| 2023 | -0.25x | CN¥-39.96 Million | CN¥160.70 Million | CN¥200.66 Million | ▲ +61.0% |
| 2022 | -0.64x | CN¥-81.43 Million | CN¥127.59 Million | CN¥209.02 Million | ▼ -188.7% |
| 2021 | -0.22x | CN¥-30.58 Million | CN¥138.34 Million | CN¥168.92 Million | ▲ +75.3% |
| 2020 | -0.89x | CN¥-82.24 Million | CN¥91.94 Million | CN¥174.18 Million | ▲ +92.8% |
| 2017 | -12.38x | CN¥-45.01 Million | CN¥3.64 Million | CN¥48.64 Million | ▼ -3713.7% |
| 2016 | 0.34x | CN¥24.07 Million | CN¥70.28 Million | CN¥46.21 Million | ▼ -38.7% |
| 2015 | 0.56x | CN¥34.71 Million | CN¥62.12 Million | CN¥27.41 Million | ▼ -15.8% |
| 2014 | 0.66x | CN¥46.13 Million | CN¥69.50 Million | CN¥23.37 Million | ▲ +290.1% |
| 2013 | 0.17x | CN¥6.33 Million | CN¥37.17 Million | CN¥30.85 Million | ▼ -72.9% |
| 2012 | 0.63x | CN¥10.64 Million | CN¥16.94 Million | CN¥6.30 Million | ▲ +200.9% |
| 2011 | 0.21x | CN¥5.01 Million | CN¥24.00 Million | CN¥18.98 Million | ▲ +195.9% |
| 2010 | -0.22x | CN¥-1.83 Million | CN¥8.43 Million | CN¥10.26 Million | ▼ -652.3% |
| 2009 | 0.04x | CN¥545.39K | CN¥13.83 Million | CN¥13.29 Million | ▲ +105.4% |
| 2008 | -0.73x | CN¥-12.80 Million | CN¥17.44 Million | CN¥30.25 Million | ▲ +2.4% |
| 2007 | -0.75x | CN¥-6.04 Million | CN¥8.03 Million | CN¥14.08 Million | ▲ +69.5% |
| 2006 | -2.47x | CN¥-25.05 Million | CN¥10.14 Million | CN¥35.19 Million | ▼ -7.0% |
| 2005 | -2.31x | CN¥-8.82 Million | CN¥3.82 Million | CN¥12.65 Million | ▼ -324.0% |
| 2004 | -0.54x | CN¥-1.85 Million | CN¥3.39 Million | CN¥5.24 Million | ▼ -179.0% |
| 2002 | 0.69x | CN¥13.25 Million | CN¥19.22 Million | CN¥5.97 Million | — |